Effectiveness and Safety of Maintenance Treatment With Combination of Tiotropium and Olodaterol in Comparison to Maintenance Treatment With a Combination of Inhaled Corticosteroids and Long-acting β2 Agonists in COPD Patients
Latest Information Update: 22 Mar 2021
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
Most Recent Events
- 15 Mar 2021 Results published in the Advances in Therapy
- 26 Nov 2019 Status changed from not yet recruiting to completed.
- 01 Nov 2019 New trial record